REMEDIES FOR RARE DISEASES
Orphanbiotec develops plant-based drugs against diseases affecting a minority, but with 6000 different diseases, but at least 30 million Europeans. For example, drugs against stomach cancer. CEO Frank Grossman is currently collaborating with other scientists on a drug that can be used to detect tumors at an early stage and thus be treated in time. Orphanbiotec plans to launch a second project against a rare metabolic disease at the end of the year.